Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph R Calabrese

Showing results (161-170 of 334) with videos related to

Pageof 34
Sort By:
Psychopharmacology Bulletin|March 28, 2022
Protein Biomarkers in Monocytes and CD4<sup>+</sup> Lymphocytes for Predicting Lithium Treatment Response of Bipolar Disorder: a Feasibility Study with Tyramine-Based Signal-Amplified Flow CytometryKeming Gao, Marzieh Ayati, Mehmet Koyuturk, et al.
The Journal of Clinical Psychiatry|August 6, 2009
Correlates of historical suicide attempt in rapid-cycling bipolar disorder: a cross-sectional assessmentKeming Gao, Bryan K Tolliver, David E Kemp, et al.
Journal of Affective Disorders|February 22, 2023
Differences in intracellular protein levels in monocytes and CD4<sup>+</sup> lymphocytes between bipolar depressed patients and healthy controls: A pilot study with tyramine-based signal-amplified flow cytometryKeming Gao, Marzieh Ayati, Nicholas M Kaye, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 2, 2006
Influence of sub-syndromal symptoms after remission from manic or mixed episodesMauricio Tohen, Charles L Bowden, Joseph R Calabrese, et al.
International Journal of Bipolar Disorders|June 11, 2018
Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label studyJoseph R Calabrese, Na Jin, Brian Johnson, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 30, 2011
Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profilesDavid E Kemp, Onur N Karayal, Joseph R Calabrese, et al.
The Journal of Clinical Psychiatry|January 2, 2007
Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trialsMark A Frye, Lakshmi N Yatham, Joseph R Calabrese, et al.
The Journal of Clinical Psychiatry|August 20, 2009
Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placeboJoseph F Goldberg, Joseph R Calabrese, Benjamin R Saville, et al.
Journal of Affective Disorders|July 26, 2011
Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesityDavid E Kemp, Faramarz Ismail-Beigi, Stephen J Ganocy, et al.
The American Journal of Psychiatry|September 23, 2021
Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled TrialJoseph R Calabrese, Suresh Durgam, Andrew Satlin, et al.
Pageof 34

Showing results (161-170 of 334) with videos related to

Sort By:
Pageof 34
Psychopharmacology Bulletin|March 28, 2022
Protein Biomarkers in Monocytes and CD4<sup>+</sup> Lymphocytes for Predicting Lithium Treatment Response of Bipolar Disorder: a Feasibility Study with Tyramine-Based Signal-Amplified Flow CytometryKeming Gao, Marzieh Ayati, Mehmet Koyuturk, et al.
The Journal of Clinical Psychiatry|August 6, 2009
Correlates of historical suicide attempt in rapid-cycling bipolar disorder: a cross-sectional assessmentKeming Gao, Bryan K Tolliver, David E Kemp, et al.
Journal of Affective Disorders|February 22, 2023
Differences in intracellular protein levels in monocytes and CD4<sup>+</sup> lymphocytes between bipolar depressed patients and healthy controls: A pilot study with tyramine-based signal-amplified flow cytometryKeming Gao, Marzieh Ayati, Nicholas M Kaye, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 2, 2006
Influence of sub-syndromal symptoms after remission from manic or mixed episodesMauricio Tohen, Charles L Bowden, Joseph R Calabrese, et al.
International Journal of Bipolar Disorders|June 11, 2018
Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label studyJoseph R Calabrese, Na Jin, Brian Johnson, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 30, 2011
Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profilesDavid E Kemp, Onur N Karayal, Joseph R Calabrese, et al.
The Journal of Clinical Psychiatry|January 2, 2007
Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trialsMark A Frye, Lakshmi N Yatham, Joseph R Calabrese, et al.
The Journal of Clinical Psychiatry|August 20, 2009
Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placeboJoseph F Goldberg, Joseph R Calabrese, Benjamin R Saville, et al.
Journal of Affective Disorders|July 26, 2011
Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesityDavid E Kemp, Faramarz Ismail-Beigi, Stephen J Ganocy, et al.
The American Journal of Psychiatry|September 23, 2021
Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled TrialJoseph R Calabrese, Suresh Durgam, Andrew Satlin, et al.
Pageof 34